Skip to content
Open access

Blood Gene Expression Profiles for Early Identification of Sepsis in Children with Cancer and Episodes of Fever and Neutropenia

Aug 2026 · Journal of the Pediatric Infectious Diseases Society · Vol 15, pp. S25-S25 · 0 citations

TL;DR

The potential value of blood gene expression profiling for classifying children with cancer and FN according to their clinical risk classification is highlighted and a deeper understanding of the pathways that are activated or suppressed in sepsis in this population is provided.

Abstract

Invasive bacterial infections are a leading cause of mortality in children with cancer and febrile neutropenia (FN). Clinical tools have been developed to predict sepsis in this population but the added value of comprehensive biomarkers such as RNA expression profiling remains unclear. This study aimed to determine the utility of transcriptome profiling for early sepsis identification in children with cancer and FN. Prospective, multicenter study conducted over three years in 6 hospitals in Chile in which children ≤ 18 years with cancer and FN were enrolled within 2 hours of fever onset, and blood samples obtained for blood culture and RNA expression profile analyses. Healthy age-matched controls (HC) were enrolled in parallel. A validated clinical scoring system was used to classify children in low and high-risk. Gene expression data was analyzed using linear regression and differential expressed genes were obtained with adjusted p-value < 0.05 and fold change > 2 in R environment. Modular analysis and quantitative gene set enrichment were used to identify pathways and network differences between groups. Data from 137 episodes of FN and in 34 healthy controls were analyzed. Median age was 8 (IQR: 6-12) years and 68 (50%) were male. The underlying diseases included hematological malignancies in 99 (72.3%) and solid tumor in 38 (27.7%) children. Of the137 episodes, 43 were classified as low risk -- and most (n=39; 91%) had a respiratory virus identified--, and 94 episodes were classified as high-risk. Of the high-risk episodes 22 developed sepsis, 20 of which had a positive blood culture. Pairwise comparisons identified 791significantly expressed genes between low-risk children and HC, while 991 genes were identified between children with sepsis and HC (Fig 1 A-B). The proportion of underexpressed genes was higher in children with sepsis (~70%) than in the low-risk group (~50%). Further, modular pathway analysis showed underexpression of inflammation, T and B-cell genes irrespective of the clinical classification, while interferon, monocyte, and neutrophil genes were overexpressed in the low-risk group but underexpressed in children with sepsis (Fig 1C). This study highlights the potential value of blood gene expression profiling for classifying children with cancer and FN according to their clinical risk classification. It also provides a deeper understanding of the pathways that are activated or suppressed in sepsis in this population.

Read PDF

Similar papers

Open access Sep 2026

Exploratory study on blood and urine transcriptomes for identifying miRNA biomarkers in pediatric febrile bacterial and viral infections

Modern clinical practice lacks rapid, reliable, and non-invasive methods to distinguish between bacterial and viral infections. It negatively impacts the effectiveness of treatment and increases the risk of unnecessary antibiotic administration and thus antibiotic resistance spread. Using microRNA (miRNA) biomarkers in...

T. Kiseļova, B. Vilne, Gunda Zvīgule-Neidere et al. · 0 citations
Open access Oct 2026

Monocyte microRNA signatures in late-onset neonatal sepsis

Purpose Neonatal late-onset sepsis (LOS) remains a major cause of neonatal morbidity and its non-specific presentation challenges early diagnosis. MicroRNAs (miRNAs) are promising biomarkers, but unbiased next-generation sequencing (NGS) of monocyte-specific miRNA has not been applied to neonatal LOS. We aimed to ident...

Eleni Gkouti, Adamantia Kouvela, E. Papachatzi et al. · 0 citations
Open access Oct 2026

Targeted proteomics in late-onset neonatal sepsis: an exploratory analysis.

Clinical and in vitro analyses identified biologically relevant candidate biomarkers that may support future diagnostic and monitoring strategies for neonatal sepsis in preterm infants and identified proteins related to inflammatory signaling, growth, and metabolic pathways.

Janno S. Schouten, Şerife Kurul, R. Gorissen et al. · 0 citations
Open access Oct 2026

Prognostic value of T lymphocyte CD40L expression levels in patients with sepsis

Background This study aimed to analyze the expression characteristics of CD40L on peripheral blood T lymphocytes in patients with sepsis and explore its value in assessing disease severity and prognosis. Methods This prospective study collected blood samples and clinical data from adult sepsis patients admitted to the...

Bing Shao, Zi-Yi Huang, Yu-Jie Liu et al. · 0 citations
Open access Oct 2026

Serum and cerebrospinal fluid biomarkers for risk stratification of hospitalized neonates and young infants with suspected serious bacterial infections: a secondary analysis of a prospective cohort study

Serum levels of TRAIL showed an exploratory association with disease severity in hospitalized neonates and young infants with suspected serious bacterial infections, and PCT was the strongest predictor of severe progression for in-hospital death.

Chaymae El Abbass, Luis Alberto Benegas, A. Alemany et al. · 0 citations
Open access Oct 2026

Plasma metabolomic profiling identifies candidate biomarkers associated with sepsis diagnosis and mortality prediction

Introduction Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection; its early diagnosis and mortality prediction remain challenging, and conventional markers (CRP, PCT) have limited sensitivity and specificity. We aimed to characterize the plasma metabolome of sepsis and ide...

Yan-Yan Zhu, Hao-Cheng Wang, Sanjun Yi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.